Sensorion SA Profile Avatar - Palmy Investing

Sensorion SA

Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin def…

Biotechnology
FR, Montpellier [HQ]
End of ALSEN.PA's Analysis
CIK: - CUSIP: F8312Z102 ISIN: FR0012596468 LEI: - UEI: -
Secondary Listings
ALSEN.PA has no secondary listings inside our databases.